Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05794139
PHASE2

Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy

Sponsor: NMD Pharma A/S

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3

Official title: A Phase 2, Randomised, Double-blind, Placebo-controlled, 2-way Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 in Ambulatory Adults With Type 3 Spinal Muscular Atrophy

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

54

Start Date

2023-09-21

Completion Date

2026-05

Last Updated

2026-02-13

Healthy Volunteers

No

Interventions

DRUG

NMD670

Tablets

DRUG

Placebo

Tablets

Locations (31)

UCLA David Geffen School Of Medicine - Neurology

Los Angeles, California, United States

Stanford University Medical Center

Palo Alto, California, United States

University of Colorado Neurology Clinic

Aurora, Colorado, United States

UF Fixel Institute for Neurological Diseases

Gainesville, Florida, United States

Rare Disease Center

Atlanta, Georgia, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

The Johns Hopkins Medicine, Spinal Muscular Atrophy Center

Baltimore, Maryland, United States

Roy Blunt NextGen Precision Health Institute

Columbia, Missouri, United States

Washington University School of Medicine

St Louis, Missouri, United States

Rare Disease Research - Raleigh-Durham

Hillsborough, North Carolina, United States

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Neurology Rare Disease Center

Denton, Texas, United States

UZ Leuven - Neurochirurgie Campus Gasthuisberg

Leuven, Belgium

CHR de la Citadelle - Neurologie

Liège, Belgium

Heritage Medical Research Clinic

Calgary, Canada

Genge Partners Inc.

Montreal, Canada

Aarhus Universitetshospital, Neurologisk Afdeling

Aarhus, Denmark

Rigshospitalet - Neurologisk Afdeling

Copenhagen, Denmark

Charite - Campus Virchow-Klinikum (CVK)

Berlin, Germany

Universitätsklinikum Essen - Klinik Für Neurologie

Essen, Germany

Istituto Giannina Gaslini, IRCCS

Genova, Italy

Istituto Neurologico C. Besta, Fondazione IRCCS

Milan, Italy

Ospedale Niguarda, ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy

Università degli studi di Pisa

Pisa, Italy

PU A. Gemelli, Università Cattolica del Sacro Cuore

Roma, Italy

AOU Città della Salute e della Scienza di Torino

Torino, Italy

Universitair Medisch Centrum Utrecht, locatie Academisch Zie - Neurology

Utrecht, Netherlands

Hospital Universitari Vall D Hebron

Barcelona, Spain

H. Donostia

Donostia / San Sebastian, Spain

Hospital Materno Infantil La Paz

Madrid, Spain

Hospital Universitario y Politécnico La Fe

Valencia, Spain